Sign in
8-K

Current Report

Oruka Therapeutics, Inc. Filed Acc 0001193125-14-034018

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading d667914d8k.htm…